Back to search

Ireland· IE-PA-EU/1/99/097/001

Beromun 1 mg powder for solution for infusion

A tasonermin product containing tumour necrosis factor alfa 1a, registered in Ireland by Belpharma S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC L03AX11

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedBeromun 1 mg powder for solution for …ATCL03AX11REGISTER NO.IE-PA-EU/1/99/097/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Tasonermin is registered in 10 of 19 countries.

Countries holding a registration under ATC L03AX11 (tasonermin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Tasonermin · ATC L03AX11

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Tumour necrosis factor alfa 1a
Manufacturer
Belpharma S.A.
Country
Ireland (IE)
ATC code
L03AX11
ATC class
Tasonermin
Defined daily dose
3.5 mg, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/99/097/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/41584dbc-047a-4dea-82bd-27f4f4b565b8
GET /v1/drugs/41584dbc-047a-4dea-82bd-27f4f4b565b8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "routes": [
    "Unknown"
  ],
  "source": "hpra",
  "atc_all": [
    "L03AX",
    "L03AX11"
  ],
  "strength": null,
  "pa_number": "EU/1/99/097/001",
  "substances": [
    "Tumour necrosis factor alfa 1a"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "13/04/1999",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about tasonermin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.